These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24225488)

  • 41. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
    Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
    J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands.
    Terry GE; Hirvonen J; Liow JS; Zoghbi SS; Gladding R; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Donohue SR; Pike VW; Halldin C; Innis RB
    J Nucl Med; 2010 Jan; 51(1):112-20. PubMed ID: 20008988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
    Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.
    Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-in-human evaluation of [
    Kim MJ; Lee JH; Juarez Anaya F; Hong J; Miller W; Telu S; Singh P; Cortes MY; Henry K; Tye GL; Frankland MP; Montero Santamaria JA; Liow JS; Zoghbi SS; Fujita M; Pike VW; Innis RB
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3143-3151. PubMed ID: 32399622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.
    McGinnity CJ; Shidahara M; Feldmann M; Keihaninejad S; Riaño Barros DA; Gousias IS; Duncan JS; Brooks DJ; Heckemann RA; Turkheimer FE; Hammers A; Koepp MJ
    Neuroimage; 2013 Oct; 79():72-80. PubMed ID: 23597934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with
    Takahata K; Seki C; Kimura Y; Kubota M; Ichise M; Sano Y; Yamamoto Y; Tagai K; Shimada H; Kitamura S; Matsuoka K; Endo H; Shinotoh H; Kawamura K; Zhang MR; Takado Y; Higuchi M
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3150-3161. PubMed ID: 35022846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 52. Modeling of [
    Schildt A; de Vries EFJ; Willemsen ATM; Moraga-Amaro R; Lima-Giacobbo B; Sijbesma JWA; Sossi V; Dierckx RAJO; Doorduin J
    Mol Imaging Biol; 2020 Aug; 22(4):931-939. PubMed ID: 31907846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parametric Methods for Dynamic
    Mansor S; Yaqub M; Boellaard R; Froklage FE; de Vries A; Bakker ED; Voskuyl RA; Eriksson J; Schwarte LA; Verbeek J; Windhorst AD; Lammertsma AA
    J Nucl Med; 2017 Mar; 58(3):479-483. PubMed ID: 27660142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation.
    Tóth M; Doorduin J; Häggkvist J; Varrone A; Amini N; Halldin C; Gulyás B
    PLoS One; 2015; 10(5):e0125917. PubMed ID: 25996996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans.
    Wong DF; Ostrowitzki S; Zhou Y; Raymont V; Hofmann C; Borroni E; Kumar A; Parkar N; Brašić JR; Hilton J; Dannals RF; Martin-Facklam M
    Neuroimage; 2013 Jul; 75():282-290. PubMed ID: 22155032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
    Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L
    J Nucl Med; 2012 Mar; 53(3):415-24. PubMed ID: 22323782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of
    Tyacke RJ; Myers JFM; Venkataraman A; Mick I; Turton S; Passchier J; Husbands SM; Rabiner EA; Gunn RN; Murphy PS; Parker CA; Nutt DJ
    J Nucl Med; 2018 Oct; 59(10):1597-1602. PubMed ID: 29523627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.